Cantor Fitzgerald
Cantor Fitzgerald is a leading brokerage service for Wall Street's fixed income inter-dealer community. Cantor is a recognized leader in the specialized areas of equity and fixed income capital markets, offering an impressive array of products and services to more than 5000 institutional clients around the world.
Cantor suffered a devastating loss on September 11, 2001, when the World Trade Center terrorist attacks claimed the lives of 658 of the company's 960 New York-based employees.
Howard W. Lutnick is the company's Chairman and CEO.
View Older Stories View More Recent Stories
-
Form N-PX CANTOR FITZGERALD SECURI For: Jun 30
-
Form N-PX CANTOR FITZGERALD, L. For: Jun 30
-
Form N-PX CANTOR FITZGERALD & CO. For: Jun 30
-
Cantor Fitzgerald Reiterates Polestar Automotive (PSNY) at Overweight following CEO change, 'expect delivery volume and margin progression to improve materially in 2H24'
-
3D Systems (DDD) PT Lowered to $3.75 at Cantor Fitzgerald
-
Stratasys Inc. (SSYS) PT Lowered to $12 at Cantor Fitzgerald
-
Form N-PX CANTOR FITZGERALD INFRAS For: Jun 30
-
Cytokinetics to Participate in September Investor Conferences
-
Form NPORT-P CANTOR FITZGERALD INFRAS For: Jun 30
-
Anaptys Announces Participation in September Investor Conferences
-
Polestar shares rebound on funding boost, margins reassure
-
Adagene to Participate in Investor Conferences in September
-
Q32 Bio to Participate in Upcoming September Investor Conferences
-
Iris Energy Ltd. (IREN) PT Lowered to $20 at Cantor Fitzgerald
-
CrowdStrike Holdings (CRWD) PT Lowered to $350 at Cantor Fitzgerald
-
Cantor Fitzgerald Reiterates Overweight Rating on NVIDIA (NVDA), 'Buy on Weakness', 'Remains Our Top Pick'
-
iTeos to Participate in Upcoming Investor Conferences
-
Cabaletta Bio to Participate in Upcoming Investor Conferences in September
-
X4 Pharmaceuticals to Participate in Upcoming September Investor Conferences
-
Kymera Therapeutics to Participate in Upcoming September Investor Conferences
-
Immunic to Host Multiple Sclerosis R&D Day and Participate in Scientific and Investor Conferences in September
-
Arcturus Therapeutics to Attend Upcoming Investor & Scientific Conferences
-
LeMaitre to Participate at Upcoming Investor Conferences in September
-
Rocket Pharmaceuticals to Participate in Upcoming Investor Conferences
-
Remix Therapeutics to Participate in Upcoming Investor Conferences
-
Structure Therapeutics Announces Participation in Upcoming Investor Conferences
-
LifeMD to Participate in Three Investor Conferences During September
-
Trump's Wall Street middleman taps network for potential administration roles
-
Form N-PX CANTOR FITZGERALD INVEST For: Jun 30
-
Zai Lab Announces Participation in September Investor Conferences
-
Arcus Biosciences to Participate in Two Upcoming Investor Conferences
-
aTyr Pharma to Participate in September Investor Conferences
-
DocGo Announces Participation at Four Upcoming Investor Conferences
-
Cantor Fitzgerald Starts MicroStrategy (MSTR) at Overweight
-
Cantor Fitzgerald Reiterates Overweight Rating on SI-BONE Inc. (SIBN)
-
Palo Alto Networks (PANW) PT Raised to $400 at Cantor Fitzgerald
-
Cantor Fitzgerald Starts ARS Pharmaceuticals Inc (SPRY) at Overweight
-
Form 424B3 Cantor Fitzgerald Income
-
HCM II Acquisition Corp. Announces Closing of $230,000,000 Initial Public Offering
-
Avidity Biosciences Announces Closing of Upsized Public Offering of Common Stock, Including Full Exercise of Underwriters' Option to Purchase Additional Shares
-
Trump taps major donors to lead transition effort should he return to power
-
Form N-23C3A CANTOR FITZGERALD INFRAS For: Aug 16
-
Kimball Electronics (KE) PT Lowered to $22 at Cantor Fitzgerald
-
Cantor Fitzgerald Upgrades Teradyne (TER) to Overweight, Added to Top Pick List
-
Cantor Fitzgerald Starts Y-mAbs Therapeutics (YMAB) at Overweight
-
HCM II Acquisition Corp Announces Pricing of $200 Million Initial Public Offering
-
Avidity Biosciences Inc. (RNA) Prices Upsized 7.32M Share Offering at $41/sh
-
Avidity Biosciences Announces Pricing of Upsized Public Offering of Common Stock
-
Cantor Equity Partners, Inc. Announces Closing of $100 Million Initial Public Offering
-
Orchid Island Capital Announces August 2024 Monthly Dividend and July 31, 2024 RMBS Portfolio Characteristics

